Clinical Trial: Retrospective and Prospective Observational Study on Aponermin-based Regimens in the Treatment of Relapsed and Refractory Multiple Myeloma with Thrombocytopenia (China)

Posted On: 2026-09-17

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Retrospective and Prospective Observational Study on Aponermin-based Regimens in the Treatment of Relapsed and Refractory Multiple Myeloma with Thrombocytopenia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132654

Registration Time: 2026/09/16

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=305116

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Retrospective and Prospective Observational Study on Aponermin-based Regimens in the Treatment of Relapsed and Refractory Multiple Myeloma with Thrombocytopenia (China)